Wasatch Advisors Lp - Sep 30, 2025 SCHEDULE 13G/A Report for Esperion Therapeutics Inc COM (ESPR)

Filing Manager: Wasatch Advisors Lp
Reporting Manager: Wasatch Advisors LP
Security: Esperion Therapeutics Inc COM
Symbol: ESPR
Shares outstanding: 202M shares
Disclosed Ownership: 7.06M shares
Ownership: 3.5%
Form type: SCHEDULE 13G/A
Date filed: 11/12/2025, 03:32 PM
Date of event: Sep 30, 2025
Previous filing: Apr 7, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Wasatch Advisors LP	3.5%	7.06M	6.22M	0	Mike Yeates	CEO